| Original language | English (US) |
|---|---|
| Pages (from-to) | 135-137 |
| Number of pages | 3 |
| Journal | Nature Reviews Clinical Oncology |
| Volume | 7 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 1 2010 |
Fingerprint
gemcitabine
Antineoplastic Antimetabolites
Deoxycytidine
Standard of Care
Pancreatic Neoplasms
Drug Therapy
ASJC Scopus subject areas
- Oncology
Cite this
@article{ea53725db2294aea9f54183f01c1ffe3,
title = "Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer",
author = "Jordan Berlin and {Benson III}, {Al B}",
year = "2010",
month = "3",
day = "1",
doi = "10.1038/nrclinonc.2010.16",
language = "English (US)",
volume = "7",
pages = "135--137",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",
}
Berlin, J & Benson III, AB 2010, 'Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer', Nature Reviews Clinical Oncology, vol. 7, no. 3, pp. 135-137. https://doi.org/10.1038/nrclinonc.2010.16
Chemotherapy : Gemcitabine remains the standard of care for pancreatic cancer. / Berlin, Jordan; Benson III, Al B.
In: Nature Reviews Clinical Oncology, Vol. 7, No. 3, 01.03.2010, p. 135-137.Research output: Contribution to journal › Short survey
TY - JOUR
T1 - Chemotherapy
T2 - Gemcitabine remains the standard of care for pancreatic cancer
AU - Berlin, Jordan
AU - Benson III, Al B
PY - 2010/3/1
Y1 - 2010/3/1
UR - http://www.scopus.com/inward/record.url?scp=77749277610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77749277610&partnerID=8YFLogxK
U2 - 10.1038/nrclinonc.2010.16
DO - 10.1038/nrclinonc.2010.16
M3 - Short survey
C2 - 20190797
AN - SCOPUS:77749277610
VL - 7
SP - 135
EP - 137
JO - Nature Reviews Clinical Oncology
JF - Nature Reviews Clinical Oncology
SN - 1759-4774
IS - 3
ER -